Anonymous User
Login / Registration

Gastroenterologie
a hepatologie

Gastroenterology and Hepatology

Gastroent Hepatol 2021; 75(2): 159–164. doi: 10.48095/ccgh2021159.

Impact of methodical guidelines of gastric scintigraphy on patients’ radiation exposure

Martina Horváthová1, Zuzana Bárdyová1, Darina Budošová1, Rastislav Husťak2,3,4

+ Affiliation

Summary

Introduction:
Gastric emptying scintigraphy (GES) is a safe, noninvasive method for assessing the ability of the stomach to empty which has been used clinically for many years. It is considered as a “gold standard” to assess gastric emptying of both solids and liquids allowing assessment of early, mid and late emptying, each of which may be altered by pathology. The aim of the study was to analyse standard diagnostic approach and evaluate patients` radiation exposure, who underwent GES in Slovakia.

Methods:
A retrospective cohort study included 55 patients from 2 departments of nuclear medicine (department A, B). Patients’ radiation exposure was determined by dosimetry program IDAC-Dose2.1. The radiopharmaceutical 99mTc-DTPA, always with the same activity, was applied orally to patients at Department B. The applied activity of the radiopharmaceutical at GES was 185 MBq. The radiopharmaceutical 99mTc MAA, with various activity, was applied orally to patients at Department A.

Results:
According to ICRP60, the eff ective dose (ED) of every patient undergoing GES was 0.77 mSv and, according to ICRP103, the dose was 0.836 mSv at Department B. Patients at Department A were exposed to ionizing radiation with 5-times lower intensity, compared with patients at Department B. It was caused by radiopharmaceutical activity correction. The ED medians according to ICRP60, and according to ICRP103 were 0.167 mSv (range 0.105–0.208 mSv) and 0.181 mSv (range 0.113–0.226 mSv) at Department A, respectively.

Discussion:
Adequate correction of applied radiopharmaceutical activity is an essential part of GES guidelines and in accordance with ALARA principles. For the accuracy of GES examination, it is necessary to follow a standard 4-hour protocol and an approach which ensures full-featured utilization of the examination while decreasing patient`s radiation exposure.

Conclusion:
The results of our study show relatively low ED associated with GES, but also confi rm that the GES methodology significantly affects the patient`s radiation exposure

Keywords

efektívna dávka, evakuácia žalúdka, nukleárna medicína, radiačná záťaž, scintigrafia

To read this article in full, please register for free on this website.

Benefits for subscribers

Benefits for logged users

Literature

1. Banks KP, Syed K, Parekh M et al. Gastric emptying scan. 2020  [online]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK531503/.
2. Saadi M, Yu D, Malik Z et al. Pyloric sphincter characteristics using EndoFLIP® in gastroparesis. Rev Gastroenerol Mex 2018; 83(4): 375–384. doi: 10.1016/j.rgmx.2018.02.013.
3. Ertay T, Doğan AS, Ulker O  et al. 2014. In vitro evaluation of tc-99m radiopharmaceuticals for gastric emptying studies. Mol Imaging Radionucl Ther 2014; 23(1): 21–24. doi: 10.4274/Mirt.75047.
4. Shin AS, Camilleri M. Diagnostic assessment of diabetic gastroparesis. Diabetes 2013; 62(8): 2667–2673. doi: 10.2337/db12-1706.
5. BNMS. Guideline for Gastric Emptying – British Nuclear Medicine Society. 2017 [online]. Available from: https://cdn.ymaws.com/www.bnms. org.uk/resource/resmgr/guidelines/gastric_ emptying_guidelines_.pdf.
6. Maurer AH. Gastrointestinal motility, part 1: esophageal transit and gastric emptying. J  Nucl Med 2015; 56(8): 1229–1238. doi: 10.2967/jnumed.112.1143147.
7. Parkman HP. Idiopathic gastroparesis. Gastroenterol Clin North Am 2015; 44(1): 59–68. doi: 10.1016/j.gtc.2014.11.015.
8. Seok JW. How to interpret gastric emptying scintigraphy. J Neurogastroenterol Motil 2011; 17(2): 189–191. doi: 10.5056/jnm.2011.17.2.189.
9. NCZI SK. Činnosť nukleárnej medicíny, klinickej a  radiačnej onkológie v SR. Štatistické prehľady. 2015  [online]. Available from: http://www.nczisk.sk/Statisticke_vystupy/Tematicke_statisticke_vystupy/Onkologia/Nuklearna_medicina_klinicka_radiacna_onkologia/Pages/default.aspx.
10. NCZI SK. Činnosť nukleárnej medicíny, klinickej a  radiačnej onkológie v SR. Štatistické prehľady. 2016  [online]. Available from: http://www.nczisk.sk/Statisticke_vystupy/Tematicke_statisticke_vystupy/Onkologia/Nuklearna_medicina_klinicka_radiacna_onkologia/Pages/default.aspx.
11. NCZI SK. Činnosť nukleárnej medicíny, klinickej a  radiačnej onkológie v  SR. Štatistické prehľady. 2017  [online]. Available from: http://www.nczisk.sk/Statisticke_vystupy/Tematicke_statisticke_vystupy/Onkologia/Nuklearna_medicina_klinicka_radiacna_onkologia/Pages/default.aspx.
12. Mattsson S, Johansson L, Svegborn SL et al. Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances. Ann ICRP 2015; 44(2  Suppl): 7–321. doi: 10.1177/04664 5314558019.
13. Donohoe KJ, Maurer AH, Ziessman HA et al. Procedure guideline for adult solid-meal gastric-emptying study 3.0*. J Nucl Med Technol 2009; 37(3): 196–200. doi: 10.2967/jnmt.109.067843.
14. Mettler FA Jr, Huda W, Yoshizumi TT et al. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology 2008; 248(1): 254–263. doi: 10.1148/radiol.24 81071451.
15. St Vincent’s Hospital Sydney. Gastric emptying scan. 2015  [online]. Available from: http://www.anzctr.org.au/AnzctrAttachments/ 370723-Scintigraphy%20protocol.pdf.
16. Knight LC. Update on gastrointestinal radiopharmaceuticals and dosimetry estimates. Semin Nucl Med 2012; 42(2): 138–144. doi: 10.1053/j.semnuclmed.2011.11.001.

Kreditovaný autodidaktický test